Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Investigation|December 11, 2019
Glibenclamide reverses cardiovascular abnormalities of Cantu syndrome driven by KATP channel overactivityConor McClenaghan, Yan Huang, Zihan Yan, et al.
JCI Insight|August 1, 2024
Mitochondrial Ca2+-coupled generation of reactive oxygen species, peroxynitrite formation, and endothelial dysfunction in Cantú syndromeElsayed Metwally, Alfredo Sanchez Solano, Boris Lavanderos, et al.
Science Advances|April 18, 2025
Live-cell quantification reveals viscoelastic regulation of synapsin condensates by α-synucleinHuan Wang, Christian Hoffmann, Johannes V Tromm, et al.
Function (Oxford, England)|September 1, 2020
The Mechanism of High-Output Cardiac Hypertrophy Arising From Potassium Channel Gain-of-Function in Cantú SyndromeConor McClenaghan, Yan Huang, Scot J Matkovich, et al.
Hormone Research in Paediatrics|January 9, 2022
Sulfonylurea-Insensitive Permanent Neonatal Diabetes Caused by a Severe Gain-of-Function Tyr330His Substitution in Kir6.2Conor McClenaghan, Novella Rapini, Domenico Umberto De Rose, et al.
JCI Insight|August 10, 2018
Cardiovascular consequences of KATP overactivity in Cantu syndromeYan Huang, Conor McClenaghan, Theresa M Harter, et al.
The Journal of Biological Chemistry|June 2, 2024
Modulation of TMEM16B channel activity by the calcium-activated chloride channel regulator 4 (CLCA4) in human cellsMonica Sala-Rabanal, Zeynep Yurtsever, Kayla N Berry, et al.
Structure (London, England : 1993)|April 11, 2017
Bilayer-Mediated Structural Transitions Control Mechanosensitivity of the TREK-2 K2P ChannelPrafulla Aryal, Viwan Jarerattanachat, Michael V Clausen, et al.
American Journal of Medical Genetics. Part A|June 9, 2019
Glibenclamide treatment in a Cantú syndrome patient with a pathogenic ABCC9 gain-of-function variant: Initial experienceAlan Ma, Sunita Gurnasinghani, Edwin P Kirk, et al.
Pageof 4